Showing results (41-50 of 90) with videos related to
Sort By:
Pageof 9
Molecular Systems Biology|January 21, 2025
Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage responseStefanie Höfer, Larissa Frasch, Sarah Brajkovic, et al.Cell Metabolism|February 11, 2014
Pdx1 maintains β cell identity and function by repressing an α cell programTao Gao, Brian McKenna, Changhong Li, et al.Oncotarget|May 21, 2016
Membranous CD24 drives the epithelial phenotype of pancreatic cancerClara Lubeseder-Martellato, Ana Hidalgo-Sastre, Carolin Hartmann, et al.Cell|January 24, 2012
EMT and dissemination precede pancreatic tumor formationAndrew D Rhim, Emily T Mirek, Nicole M Aiello, et al.Translational Oncology|September 18, 2025
Development of a translational radiobiology platform using pancreatic cancer patient-derived organoids for personalized radiation oncologyChristopher Kessler, Francheska Cadacio, Carlo Maurer, et al.British Journal of Cancer|February 1, 2018
MTOR inhibitor-based combination therapies for pancreatic cancerZonera Hassan, Christian Schneeweis, Matthias Wirth, et al.Cellular and Molecular Life Sciences : CMLS|December 19, 2022
AP1/Fra1 confers resistance to MAPK cascade inhibition in pancreatic cancerChristian Schneeweis, Sandra Diersch, Zonera Hassan, et al.Cell Reports|June 25, 2013
An iPSC line from human pancreatic ductal adenocarcinoma undergoes early to invasive stages of pancreatic cancer progressionJungsun Kim, John P Hoffman, R Katherine Alpaugh, et al.Molecular Cancer Therapeutics|September 23, 2021
Phosphoproteomics Identifies PI3K Inhibitor-selective Adaptive Responses in Pancreatic Cancer Cell Therapy and ResistanceCélia Cintas, Thibault Douche, Zahra Dantes, et al.The Lancet. Gastroenterology & Hepatology|August 19, 2024
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trialKlara Dorman, Stefan Boeck, Karel Caca, et al.Pageof 9